Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.
D000328:Adult; D000614:Aminocaproates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000799:Angioedema / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D002986:Clinical Trials as Topic; D003165:Complement System Proteins / Q000032:analysis; D003402:Creatine Kinase / Q000097:blood; D004950:Esterases / Q000037:antagonists & inhibitors; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos
D000614:Aminocaproates; D010919:Placebos; D003165:Complement System Proteins; D003402:Creatine Kinase; D004950:Esterases; D005634:Fructose-Bisphosphate Aldolase